CÔNG TY CỔ PHẦN DƯỢC PHẨM MEDBOLIDE

POZIATS Report – Da Nang Psychiatric Hospital

On the morning of May 28, 2019, at the Hall of Da Nang Psychiatric Hospital, Medbolide Joint Stock Company had a report introducing the product POZIATS (Aripirazole 5mg/10mg) with the topic "Aripiprazole - Generation antipsychotic drug new". Attending the report session was BSCK II. Lam Tu Trung (Director) and 33 Doctors of Da Nang Mental Hospital.

Clinical research results showing the novelty, broad-spectrum effectiveness, safety, low toxicity of Aripiprazole and the distinct advantages of POZIATS were reported by representatives of Medbolide Company, attracting attention. Definitely with the Doctors. Noteworthy are the studies on the effectiveness of Aripiprazole on patients with psychosis due to alcohol and drug abuse, as well as patients with concurrent schizophrenia, which is the main patient population of the hospital. Da Nang Mentality. This contributes to strengthening trust and expanding doctors' treatment options for psychotic patients.

At the end of the presentation, Hospital Director - BSCKII. Lam Tu Trung - has had  conclusions that reaffirm the novelty and specialness of the mechanism of action of Aripiprazole, and an overall assessment of the distinct advantages of Aripiprazole compared to other antipsychotic active ingredients.

With the mission of improving the health quality of Vietnamese people, Medbolide Company hopes to continue accompanying doctors and patients with products with good treatment effects, providing solutions for diseases. mental illness in particular and other diseases in general.

Pic 1
Pic 2
Readers comments